Low-grade neuroendocrine tumor of the corpus uteri
diseaseOn this page
Also known as low-grade neuroendocrine tumor of the uterine corpuslow-grade neuroendocrine tumour of the uterine corpuswell-differentiated neuroendocrine neoplasm of the endometriumwell-differentiated neuroendocrine tumor of the corpus uteriwell-differentiated neuroendocrine tumor of the endometriumwell-differentiated neuroendocrine tumour of the corpus uteriwell-differentiated neuroendocrine tumour of the endometrium
Summary
Low-grade neuroendocrine tumor of the corpus uteri (MONDO:0016270) is a cancer. A subtype of uterine corpus cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | low-grade neuroendocrine tumor of the corpus uteri |
| Mondo ID | MONDO:0016270 |
| Orphanet | 213736 |
| NCIT | C126773 |
| UMLS | C5190779 |
| MedGen | 1672976 |
| GARD | 0020483 |
| Is cancer (heuristic) | yes |
Also known as: low-grade neuroendocrine tumor of the uterine corpus · low-grade neuroendocrine tumour of the uterine corpus · well-differentiated neuroendocrine neoplasm of the endometrium · well-differentiated neuroendocrine tumor of the corpus uteri · well-differentiated neuroendocrine tumor of the endometrium · well-differentiated neuroendocrine tumour of the corpus uteri · well-differentiated neuroendocrine tumour of the endometrium
Disease family
This is a subtype of uterine corpus cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › reproductive system cancer › female reproductive organ cancer › uterine cancer › uterine corpus cancer › low-grade neuroendocrine tumor of the corpus uteri
Related subtypes (11): uterine corpus endometrial carcinoma, uterine body mixed cancer, uterine corpus sarcoma, endometrial serous adenocarcinoma, squamous cell carcinoma of the corpus uteri, undifferentiated carcinoma of the corpus uteri, papillary carcinoma of the corpus uteri, high-grade neuroendocrine carcinoma of the corpus uteri, adenoid cystic carcinoma of the corpus uteri, transitional cell carcinoma of the corpus uteri, malignant germ cell tumor of corpus uteri
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.